Inotuzumab Ozogamicin Injection

225 interactions 104 cited references

Also sold as: Besponsa Besponsa®

About Inotuzumab Ozogamicin Injection

Inotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Pimozide Piperaquine Rubella Virus Vaccine, Live Saquinavir Smallpox Monkeypox Vaccine Sparfloxacin

21 Contraindicated 204 Major

All (225) Contraindicated (21) Major (204)

Major

Inotuzumab Ozogamicin Injection Phenobarbital Fidoquel An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pimavanserin Nuplazid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pipamperone Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Pitolisant Wakix Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ponesimod Ponvory An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Posaconazole Noxafil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Primidone Mysoline An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Probucol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Procainamide Procan® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Prochlorperazine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Promethazine Phenadoz Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Propafenone Rythmol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Protriptyline Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Quetiapine Seroquel Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Quinidine Cardioquin® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Quinine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Quizartinib Vanflyta An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ranolazine Aspruzyo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Relugolix Orgovyx Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Revumenib Revuforj An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ribociclib Kisqali Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Rilpivirine Edurant An increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Risperidone Perseris Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ritonavir Norvir Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Selpercatinib Retevmo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sertindole Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sertraline An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sevoflurane Petrem Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Siponimod Mayzent An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sodium Phosphate OsmoPrep Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sodium Phosphate, Dibasic Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sodium Phosphate, Monobasic Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Solifenacin Vesicare Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sorafenib Nexavar Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sotalol Betapace Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sulpiride Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sultopride Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Sunitinib Sutent Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Tacrolimus Astagraf Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.